Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicenter Open-label Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia

NCT01251627 is registered in ClinicalTrials.gov with Fondazione Italiana Sindromi Mielodisplastiche-ETS as lead sponsor.

NCT NCT01251627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01251627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicenter Open-label Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia
Lead sponsor
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
June 30, 2018
Enrollment
43 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia